Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Graft-Versus-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02485535
What this trial is testing

Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant

Who this might be right for
Acute Myeloid Leukemiade Novo Myelodysplastic SyndromeMyelodysplastic Syndrome+2 more
University of Chicago 12
Not applicableLooking for participantsNCT06742008
What this trial is testing

Assessment of the Predictive Value of Anti-beta1AR and Anti-L-CaC Antibodies in the Evolution to Dilated Cardiomyopathy in Patients With Acute Viral Myocarditis

Who this might be right for
Viral Myocarditis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 300
Very early researchUnknownNCT02937376
What this trial is testing

Effects of N-acetyl Cystein (NAC) Supplementation in G6PD Deficient Individuals After Acute Exercise

Who this might be right for
G6PD Deficiency
University of Thessaly 12
Not applicableLooking for participantsNCT07181317
What this trial is testing

WAMIF: Prospective Study in Young Women Presenting Acute Myocardial Infarction: Cohort Follow up

Who this might be right for
Myocardial Infarction, Acute
French Cardiology Society 314
Not applicableNot Yet RecruitingNCT07545889
What this trial is testing

Multicenter Prospective Study Analyzing the Occurrence of Multiple Sclerosis Relapses Without Radiological Evidence: Myth or Reality?

Who this might be right for
Multiple SclerosisRRMSMultiple Sclerosis (MS) - Relapsing-remitting
University Hospital, Strasbourg, France 136
Not applicableEnded earlyNCT03439150
What this trial is testing

Resistance STEMI Study

Who this might be right for
STEMIAcute Myocardial Infarction
Catharina Ziekenhuis Eindhoven 5
Testing effectiveness (Phase 2)WithdrawnNCT04200950
What this trial is testing

Trial for the Early Identification of Acute Kidney Injury

Who this might be right for
Acute Kidney Injury
Dascena
Large-scale testing (Phase 3)Study completedNCT00640991
What this trial is testing

REsearching Coronary REduction by Appropriately Targeting Euglycemia (RECREATE Pilot Study)

Who this might be right for
HyperglycemiaCardiovascular DiseasesMyocardial Infarction
Population Health Research Institute 500
Not applicableStudy completedNCT04916626
What this trial is testing

The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis

Who this might be right for
SchizophreniaSchizotypal DisorderDelusional Disorder+5 more
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital 284
Not applicableStudy completedNCT01857635
What this trial is testing

Use of TpCO2 (Transcutaneous CO2 Measurement) as PaCO2 Predictor During NIV in Case of Acute Hypercapnic Respiratory Failure

Who this might be right for
Hypercapnic Respiratory Failure
University of Lausanne Hospitals 20
Not applicableStudy completedNCT02010125
What this trial is testing

Feasibility Trial Using Imaging and Biochemical Technologies to Measure Knee Cartilage Composition in Acute ACL Injury

Who this might be right for
Acute Injury of Anterior Cruciate Ligament
University of California, San Francisco 89
Large-scale testing (Phase 3)UnknownNCT03631589
What this trial is testing

MSC for Severe aGVHD

Who this might be right for
Steroid-resistant Severe aGVHD
Fujian Medical University 50
Testing effectiveness (Phase 2)Study completedNCT00391989
What this trial is testing

Treatment of Adult Ph+ LAL With BMS-354825

Who this might be right for
Lymphoblastic Leukemia, Acute
Gruppo Italiano Malattie EMatologiche dell'Adulto 53
Not applicableStudy completedNCT02360189
What this trial is testing

Mechanisms of Social Inequalities in Post-hospitalization Rehabilitation in Patients With Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome
Nordsjaellands Hospital 310
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07562568
What this trial is testing

SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMDS+4 more
The First Affiliated Hospital of Soochow University 160
Testing effectiveness (Phase 2)Study completedNCT01643668
What this trial is testing

Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Massachusetts General Hospital 34
Post-approval studies (Phase 4)UnknownNCT05624190
What this trial is testing

Intra-arterial Recombinant Human TNK Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Large Vascular Occlusion After Successful Mechanical Thrombectomy Recanalization

Who this might be right for
Ischemic Stroke, Acute
Beijing Tiantan Hospital 256
Not applicableStudy completedNCT02938260
What this trial is testing

Diltiazem vs. Metoprolol in the Acute Management of AF in Patients With HFrEF

Who this might be right for
Atrial FibrillationHeart Failure
RaeAnn Hirschy 48
Not applicableStudy completedNCT02726620
What this trial is testing

Decision Support for Intraoperative Low Blood Pressure

Who this might be right for
Hypotension
Vanderbilt University Medical Center 22,435
Testing effectiveness (Phase 2)Ended earlyNCT06679582
What this trial is testing

Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Sutro Biopharma, Inc. 24
Next Page